[ Price : $8.95]
FDA warns Indias Macsen Drugs about CGMP deviations in its production of active pharmaceutical ingredients.[ Price : $8.95]
Recognify Life Sciences says its Phase 2b trial of inidascamine, a drug candidate for treating cognitive impairment associated wit...[ Price : $8.95]
After being criticized for attempting to bypass a formal advisory committee review of warnings associated with hormone replacement...[ Price : $8.95]
FDA issues a revised draft guidance entitled Small Volume Parenteral (SVP) Drug Products and Pharmacy Bulk Packages for Parenteral...[ Price : $8.95]
FDA investigates another death of a young boy who received Sarepta Therapeutics gene therapy Elevidys for Duchenne muscular dystro...[ Price : $8.95]
Roche announces new data on its Alzheimers therapy trontinemab and its plans to begin two Phase 3 clinical trials by the end of th...[ Price : $8.95]
Bipartisan House lawmakers urge FDA to block counterfeit anti-obesity medications entering the U.S.[ Price : $8.95]
FDA reverses its enforcement stance against Sarepta Therapeutics and Duchenne Muscular Dystrophy gene therapy Elevidys after deter...